⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AXSM News
Axsome Therapeutics, Inc
Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader
globenewswire.com
AXSM
Form 8-K
sec.gov
AXSM
Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease
globenewswire.com
AXSM
$58.8 Bn LEO Satellite Markets - Global Forecast to 2036 Featuring SpaceX, Amazon (Project Kuiper), OneWeb, Telesat, Axiom Space, Relativity Space, Axiom Space, Planet Labs, Capella Space
globenewswire.com
AMZN
SPCE
AXSM
RVSN
PL
Verismo Therapeutics Presents Preclinical Data at AACR 2026 for SynKIR™-310 KIR-CAR Indicating Superior Preclinical Activity in B Cell Malignancies and Early Clinical Efficacy
prnewswire.com
AXSM
Space Foundation Premieres National Space Day Video May 1
globenewswire.com
AIR
AXSM
VOYG
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
globenewswire.com
AXSM
Centri Announces Panel Topics and Featured Programming for Second Annual Capital Conference at Nasdaq on April 14
accessnewswire.com
NDAQ
DFIN
PTGX
STRL
TNDM
AXSM
CSTL
CYTK
GILD
INSM
KODK
NBIX
OCGN
REGN
SRPT
VRTX
XBIT
AMZN
GOOGL
MSFT
NVDA
IBM
ORGN
BWEN
CCJ
EXC
NEE
SO
UTL
XOM
BALY
OXY
PBF
CHRD
AX
BAC
MAXN
PHIO
KZR
SMX
DUOT
COIN
EHTH
Form 8-K
sec.gov
AXSM
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions
globenewswire.com
AXSM